Full Text View
Tabular View
No Study Results Posted
Related Studies
An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes
This study has been terminated.
( Company decision taken in light of demands by certain national health authorities )
Study NCT00576667   Information provided by Sanofi

First Received on December 18, 2007.   Last Updated on June 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fatty Liver
More general conditions related to this trial
Digestive System Diseases
Liver Diseases
Interventions listed in this trial
rimonabant (SR141716)
Placebo
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services